Seres Therapeutics (MCRB) IPO Prices at $18, Above Expected Range

Seres Therapeutics, Inc. (NASDAQ: MCRB) announced the pricing of its initial public offering of 7,430,555 shares of common stock at a public offering price of $18.00 per share, above the expected $15-$17 range. The company's shares are expected to begin trading on The NASDAQ Global Select Market today under the ticker symbol "MCRB."

In addition, Seres Therapeutics granted the underwriters a 30-day option to purchase up to an additional 1,114,583 shares of common stock from the company at the public offering price.

Goldman, Sachs & Co. and BofA Merrill Lynch are acting as joint book-running managers for the offering, and Leerink Partners and Canaccord Genuity Inc. are acting as lead managers for the offering.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Singularity Future Technology closes $1.8M registered direct offering